Searchable abstracts of presentations at key conferences in endocrinology

ea0024bc1.3 | (1) | BSPED2010

Experience of management of children and adolescents with thyrotoxicosis in the West of Scotland 1987–2009

Altowati Mabrouka , Paterson Wendy , Ahmed Faisal , Williamson Scott , Hunt Gerald , Hunter Ian , Donaldson Malcolm

Background: Hyperthyroidism is a significant medical condition in paediatric patients with serious health consequences. Optimal treatment remains debatable.Objective: To review 23 years’ experience of paediatric hyperthyroidism in the West of Scotland.Methods: Case notes of patients treated for thyrotoxicosis in Glasgow, Paisley, Ayrshire and Lanarkshire from 1987 until 2009 inclusive were retrospectively reviewed. Patients wi...

ea0065p1 | Adrenal and Cardiovascular | SFEBES2019

Single cell RNA-seq reveals complex processing of glucocorticoid controlled transcriptional programmes

McGinnis Kathryn , Baker Syed Murtuza , Donaldson Ian , Berry Andrew , Rattray Magnus , Ray David , Stead Lucy , Cook Graham , Bond Jacquelyn , Matthews Laura

Synthetic glucocorticoids (Gc) are the most potent anti-inflammatory agents known and are widely used to treat a range of chronic inflammatory diseases including rheumatoid arthritis and asthma. However their therapeutic utility is limited by the development of Gc resistance over time – particularly at sites of inflammation. Understanding the underlying mechanisms that control Gc sensitivity is essential to overcome this. Previous studies have measured the average transcr...

ea0065p130 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

Nuclear receptor profiling predicts chemical disruptors as risk factors for developing breast cancer

Leif Freya , Pfander Pauline , Baker Syed Murtuza , Donaldson Ian , McGinnis Kathryn , Leslie Fiona , Thorne James , Cook Graham , Twelves Christopher , Speirs Valerie , Matthews Laura

Triple negative breast cancer (TNBC) represents 10–20% of all breast cancers diagnosed, affects young people and is highly aggressive. These tumours lack expression of the receptors that bind estrogen and progesterone and stratify patients for hormonal therapy. The only current therapeutic option for TNBC is chemotherapy which has limited efficacy, and therefore novel therapies are desperately needed. The receptors for estrogen and progesterone belong to the nuclear recep...